Trial · NCT02193828
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.60 mg | Surface Area | -81.61 | Standard Deviation 20.251 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.40 mg | Surface Area | -80.11 | Standard Deviation 21.459 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.25 mg | Surface Area | -58.30 | Standard Deviation 29.849 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | Placebo | Surface Area | -41.76 | Standard Deviation 32.445 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.60 mg | Volume | -89.03 | Standard Deviation 15.016 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.40 mg | Volume | -87.58 | Standard Deviation 16.372 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | AA4500 0.25 mg | Volume | -68.15 | Standard Deviation 33.859 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Caliper Measurements | Placebo | Volume | -49.13 | Standard Deviation 36.736 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.60 mg | Surface Area | -34.23 | Standard Deviation 41.353 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.40 mg | Surface Area | -19.37 | Standard Deviation 39.658 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.25 mg | Surface Area | -10.30 | Standard Deviation 41.696 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | Placebo | Surface Area | -4.54 | Standard Deviation 54.784 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.60 mg | Volume | -40.99 | Standard Deviation 46.612 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.40 mg | Volume | -13.01 | Standard Deviation 68.804 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | AA4500 0.25 mg | Volume | -9.52 | Standard Deviation 60.156 | percentage of change |
| Percent Change From Baseline in Surface Area and Volume of the Treated Nodule at Day 57 Using Ultrasound | Placebo | Volume | -7.19 | Standard Deviation 69.877 | percentage of change |
| Change From Baseline in Consistency of the Treated Nodules at Day 57 | AA4500 0.60 mg | -1.9 | Standard Deviation 0.93 | units on a scale | |
| Change From Baseline in Consistency of the Treated Nodules at Day 57 | AA4500 0.40 mg | -1.9 | Standard Deviation 1.05 | units on a scale | |
| Change From Baseline in Consistency of the Treated Nodules at Day 57 | AA4500 0.25 mg | -1.2 | Standard Deviation 1.10 | units on a scale | |
| Change From Baseline in Consistency of the Treated Nodules at Day 57 | Placebo | -0.3 | Standard Deviation 0.96 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02193828/results